The timeline for the proposed Alcon acquisition of STAAR Surgical has once again been extended as STAAR announced amendments ...

SriniVas R. Sadda, MD, FARVO, a professor of ophthalmology at UCLA and the Doheny Eye Institute, discussed advancements in ...

Advanced imaging technologies like intraoperative OCT and heads-up displays enhance surgical precision and patient outcomes ...

The US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) from Outlook ...

Apellis Pharmaceuticals recently announced post hoc analysis data of the GALE extension study. This new data is the result of ...

A study reveals that cryopreserved amniotic membrane enhances recovery and reduces infection risk in post-corneal ...

ONL Therapeutics randomizes first patient in phase 2 GALAXY trial evaluating xelafaslatide ...

Under the terms of the agreement, 4DMT will grant Otsuka exclusive rights to develop and commercialize 4D-150 for retinal vascular diseases in Japan, China, Australia, and other Asia-Pacific markets.

Second-year medical student Rishika Garg shares insights from a nationwide analysis revealing inconsistencies in ...

Paul Badawi, Founder and CEO of Sight Sciences and Leon Herndon, MD, Duke University Eye Center, Durham, NC, commented on the ...

Rishika Garg is a second-year medical student at the University of Oklahoma College of Medicine in Oklahoma City. Second-year medical student Rishika Garg shares insights from a nationwide analysis ...

Targeting Tear Function for Sustained Relief” convenes leading experts in ophthalmology and optometry to discuss evolving ...